Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 3/30

$6.24−0.07 (-1.11%)

Close on Nov 12, 2026Market cap $42.32MP/E –Yield –

Instil Bio gross margin

Gross margin is gross profit as a percentage of revenue.

Instil Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?